6,846 Shares in Cabot Co. (NYSE:CBT) Acquired by Advisory Services Network LLC

Advisory Services Network LLC purchased a new stake in Cabot Co. (NYSE:CBT - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 6,846 shares of the specialty chemicals company's stock, valued at approximately $625,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. R Squared Ltd acquired a new stake in Cabot during the 4th quarter worth about $26,000. EverSource Wealth Advisors LLC grew its stake in Cabot by 37.2% during the fourth quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock worth $74,000 after purchasing an additional 219 shares during the period. GAMMA Investing LLC increased its holdings in Cabot by 10.7% in the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock worth $123,000 after purchasing an additional 130 shares in the last quarter. Manchester Capital Management LLC lifted its stake in Cabot by 1,685.1% in the fourth quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock valued at $153,000 after buying an additional 1,584 shares during the period. Finally, Coldstream Capital Management Inc. bought a new position in shares of Cabot during the 3rd quarter worth approximately $226,000. 93.18% of the stock is owned by institutional investors.

Cabot Price Performance

NYSE CBT traded up $0.08 during trading hours on Friday, reaching $78.40. 338,411 shares of the stock traded hands, compared to its average volume of 387,326. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29. The stock has a 50 day simple moving average of $82.71 and a two-hundred day simple moving average of $94.90. Cabot Co. has a 1 year low of $73.63 and a 1 year high of $117.46. The company has a market cap of $4.25 billion, a price-to-earnings ratio of 10.41, a price-to-earnings-growth ratio of 0.74 and a beta of 1.04.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. On average, analysts predict that Cabot Co. will post 7.57 EPS for the current fiscal year.

Wall Street Analyst Weigh In

CBT has been the topic of several research analyst reports. UBS Group cut their target price on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a research note on Monday, April 7th. StockNews.com upgraded Cabot from a "hold" rating to a "buy" rating in a research note on Thursday. JPMorgan Chase & Co. cut their price target on Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a report on Friday, February 21st. Finally, Mizuho decreased their price objective on Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a report on Tuesday, January 7th.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.